Carregant...
The Risk for Anemia with Targeted Therapies for Solid Tumors
BACKGROUND. Anemia is a common manifestation in patients with cancer. Little is known about the frequency of and risk for anemia with targeted therapies used to treat solid tumors. METHODS. We performed a meta-analysis of randomized controlled trials of solid tumors by comparing targeted therapy (al...
Guardat en:
| Autors principals: | , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
AlphaMed Press
2012
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3360911/ https://ncbi.nlm.nih.gov/pubmed/22531357 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2012-0024 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|